Oruka Therapeutics, Inc. (ORKA)
80.18
-4.20
(-4.98%)
USD |
NASDAQ |
Oct 06, 16:00
80.26
+0.08
(+0.10%)
Pre-Market: 20:00
Oruka Therapeutics Max Drawdown (5Y) : 96.36% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 96.36% |
| August 31, 2026 | 96.36% |
| July 31, 2026 | 96.36% |
| June 30, 2026 | 96.36% |
| May 31, 2026 | 96.36% |
| April 30, 2026 | 96.36% |
| March 31, 2026 | 96.36% |
| February 28, 2026 | 96.36% |
| January 31, 2026 | 96.36% |
| December 31, 2025 | 96.36% |
| November 30, 2025 | 96.36% |
| October 31, 2025 | 96.53% |
| September 30, 2025 | 96.53% |
| August 31, 2025 | 96.53% |
| July 31, 2025 | 96.53% |
| June 30, 2025 | 96.62% |
| May 31, 2025 | 96.62% |
| April 30, 2025 | 98.04% |
| March 31, 2025 | 98.55% |
| February 28, 2025 | 98.78% |
| January 31, 2025 | 98.78% |
| December 31, 2024 | 98.78% |
| November 30, 2024 | 98.78% |
| October 31, 2024 | 98.78% |
| September 30, 2024 | 98.78% |
| Date | Value |
|---|---|
| August 31, 2024 | 98.78% |
| July 31, 2024 | 98.78% |
| June 30, 2024 | 98.78% |
| May 31, 2024 | 98.78% |
| April 30, 2024 | 98.78% |
| March 31, 2024 | 98.78% |
| February 29, 2024 | 98.78% |
| January 31, 2024 | 98.78% |
| December 31, 2023 | 98.78% |
| November 30, 2023 | 98.78% |
| October 31, 2023 | 98.78% |
| September 30, 2023 | 98.78% |
| August 31, 2023 | 98.78% |
| July 31, 2023 | 98.78% |
| June 30, 2023 | 98.78% |
| May 31, 2023 | 98.78% |
| April 30, 2023 | 98.78% |
| March 31, 2023 | 98.78% |
| February 28, 2023 | 98.78% |
| January 31, 2023 | 98.78% |
| December 31, 2022 | 98.78% |
| November 30, 2022 | 98.78% |
| October 31, 2022 | 98.78% |
| September 30, 2022 | 98.78% |
| August 31, 2022 | 98.78% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Tenax Therapeutics, Inc. | 99.96% |
| Exicure, Inc. | 99.73% |
| Century Therapeutics, Inc. | 98.78% |
| Absci Corp. | 96.20% |
| Celularity, Inc. | 99.54% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 30.95 |
| Beta (5Y) | -0.3730 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 75.60% |
| Historical Sharpe Ratio (5Y) | 0.36 |
| Historical Sortino (5Y) | 0.9079 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 21.40% |